Search

Your search keyword '"Takis Prinos"' showing total 3 results
Start Over Author "Takis Prinos"
3 results on '"Takis Prinos"'

1. Further Investigation of the Reduction of HTT Protein through Chemical Inhibition

Author

Jolene Ho and Takis Prinos

Subjects
symmetric dimethylation of arginine, epigenetics, huntingtin, SDMA, PRMT5, Western blot, Huntington's disease, HTT
Abstract

Funding acknowledgement The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Published
2019
Full Text
View/download PDF

2. Overexpression Of Expanded Htt In Brain Cancer Cell Lines

Author

Jolene Ho and Takis Prinos

Subjects
HD, huntington's disease, baculovirus, huntingtin, cancer, Western blot, HTT
Abstract

Funding acknowledgement The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Published
2018
Full Text
View/download PDF

3. N-Terminal Vs C-Terminal Flag-Tagged Htt

Author

Jolene Caifeng Ho and Takis Prinos

Subjects
baculovirus, FLAG, Western blot, HTT, huntington's
Abstract

Funding acknowledgement: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results